Company Filing History:
Years Active: 2017
Title: Marie Wickstrom Lindholm: Innovator in Therapeutic Oligonucleotides
Introduction
Marie Wickstrom Lindholm is a prominent inventor based in Malmo, Sweden. She has made significant contributions to the field of therapeutics, particularly in the delivery of oligonucleotides for medical applications. Her innovative work focuses on improving treatment methods for metabolic and liver disorders.
Latest Patents
Marie holds a patent for the "Oral delivery of therapeutically effective LNA oligonucleotides." This invention provides a method for administering LNA oligomers orally in a unit dose of less than 50 mgs/kg, enhanced by the presence of a penetration enhancer. This advancement has the potential to revolutionize treatment protocols for patients suffering from specific metabolic conditions.
Career Highlights
Marie Wickstrom Lindholm is associated with Roche Innovation Center Copenhagen A/S, where she continues to develop her research and innovations. Her work at Roche has positioned her as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic solutions.
Collaborations
Throughout her career, Marie has collaborated with notable colleagues, including Gregory Hardee and Ellen Marie Straarup. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic strategies.
Conclusion
Marie Wickstrom Lindholm's contributions to the field of therapeutic oligonucleotides exemplify her dedication to advancing medical science. Her innovative approaches and collaborative efforts continue to pave the way for new treatment options.